Piperacillin/Tazobactam 2 G/0,25 G Fresenius. Piperacillin/Tazobactam 4 G/0,5 G Fresenius 2 g/0,25 g & 4 g/0,5 g Powder for solution for infusion
PDF Leaflet Revision Date: 27 May 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of systemic and local bacterial infections.
Dosage (summary)
Adults: 4 g/0.5 g every 8 hours; adjust for renal impairment.
Special Populations
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Safety not established; avoid breastfeeding.
Key Drug Interactions
- Probenecid
- Oral anticoagulants
- Methotrexate
Contraindications
- Allergy to piperacillin or tazobactam
- History of hypersensitivity to beta-lactams
Common side effects
- Diarrhoea
- Nausea
- Headache
- Rash
Counselling Points
- Report any allergic reactions
- Monitor for signs of colitis
- Maintain hydration during therapy
Serious warnings
- Serious hypersensitivity reactions
- Pseudomembranous colitis
- Leukopenia
Important Disclaimer
The Piperacillin/Tazobactam 2 G/0,25 G Fresenius. Piperacillin/Tazobactam 4 G/0,5 G Fresenius 2 g/0,25 g & 4 g/0,5 g Powder for solution for infusion professional information leaflet below is the property of Fresenius Kabi South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
